The present invention relates to novel &bgr;-substituted-&bgr;-aminoethylphosphonate derivatives and their uses for lowering plasma levels of apo (a), Lp(a), apo B, apo B associated lipoproteins (low density lipoproteins and very low density lipoproteins) and for lowering plasma levels of total cholesterol.
本发明涉及新型β-取代-β-
氨基
乙基膦酸酯衍
生物及其用于降低血浆中apo(a)、Lp(a)、apo B、apo B相关脂蛋白(低密度脂蛋白和极低密度脂蛋白)
水平和降低血浆总
胆固醇水平的用途。